Cost of revenue · 2015–2025
Angiodynamics cost of revenue
$145M+7.8% · FY2025
Angiodynamics (ANGO) reported $145M in cost of revenue for fiscal 2025, +7.8% year on year.
| Fiscal year | Cost of revenue | Change | Filing |
|---|---|---|---|
| FY20252026-05-31 | $145M | +7.8% | Open → |
| FY20242025-05-31 | $135M | −9.7% | Open → |
| FY20232024-05-31 | $149M | −9.3% | Open → |
| FY20222023-05-31 | $165M | +9.3% | Open → |
| FY20212022-05-31 | $150M | +12.1% | Open → |
| FY20202021-05-31 | $134M | +17.9% | Open → |
| FY20192020-05-31 | $114M | −0.7% | Open → |
| FY20182019-05-31 | $115M | −2.7% | Open → |
| FY20172018-05-31 | $118M | −6.4% | Open → |
| FY20162017-05-31 | $126M | −29.9% | Open → |
| FY20152016-05-31 | $180M | — | Open → |
Cost of revenue — Cost of revenue is the direct cost of producing what the company sold — materials, manufacturing and the labour tied to delivery. It excludes sales, marketing and administration. Revenue minus this figure is gross profit.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2015–2025 compound annual growth −2.1%
Cost of revenue at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Angiodynamics cost of revenue |url=https://companiesranked.com/en/company/angiodynamics/cost-of-revenue |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Angiodynamics cost of revenue. CompaniesRanked. https://companiesranked.com/en/company/angiodynamics/cost-of-revenueBibTeX
@misc{companiesranked-en-company-angiodynamics-cost-of-revenue-2026,
author = {{CompaniesRanked}},
title = {{Angiodynamics cost of revenue}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/angiodynamics/cost-of-revenue}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001628280-26-048138 · July 14, 2026
{{cite web |title=Angiodynamics cost of revenue — 10-K (0001628280-26-048138) |url=https://www.sec.gov/Archives/edgar/data/1275187/000162828026048138/ango-20260531.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-07-14}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.